Latest TNM Classification for Oral Cavity Cancers
The current TNM classification for oral cavity squamous cell carcinoma is the 8th edition (AJCC/UICC), which became effective in 2017 and introduced two critical prognostic parameters: depth of invasion (DOI) for T staging and extranodal extension (ENE) for N staging 1.
Key Updates from 7th to 8th Edition
T Category Changes
The 8th edition fundamentally restructured T staging by incorporating depth of invasion (DOI) as a primary determinant 2, 1:
- T1: Tumor ≤2 cm AND DOI ≤5 mm
- T2: Tumor ≤2 cm AND DOI >5 mm but ≤10 mm, OR tumor >2 cm but ≤4 cm AND DOI ≤10 mm
- T3: Tumor >2 cm but ≤4 cm AND DOI >10 mm, OR tumor >4 cm AND DOI ≤10 mm
- T4a: Tumor >4 cm AND DOI >10 mm, OR tumor invades adjacent structures (cortical bone, maxillary sinus, skin of face)
- T4b: Tumor invades masticator space, pterygoid plates, or skull base, or encases internal carotid artery
This represents a major departure from the 7th edition, which relied solely on tumor size for T1-T3 classification 3.
N Category Changes
The 8th edition incorporated extranodal extension (ENE) as a critical adverse feature 4, 1:
- N1: Single ipsilateral node ≤3 cm, ENE(-)
- N2a: Single ipsilateral node ≤3 cm with ENE(+), OR single ipsilateral node >3 cm but ≤6 cm with ENE(-)
- N2b: Multiple ipsilateral nodes ≤6 cm, ENE(-)
- N2c: Bilateral or contralateral nodes ≤6 cm, ENE(-)
- N3a: Any node >6 cm, ENE(-)
- N3b: Any node with ENE(+) (except single ipsilateral node ≤3 cm with ENE+, which is N2a)
The 7th edition N1 with ENE is now upstaged to N2a, and any 7th edition N2+ with ENE becomes N3b 4.
Rationale for Updates
Why DOI Was Added
DOI emerged as a more powerful prognostic indicator than tumor surface diameter alone 3, 1. Research demonstrated that tumors with greater depth of invasion had significantly worse outcomes regardless of surface dimensions. The 8th edition improved hazard discrimination between T categories, with studies showing increased concordance indices when DOI was incorporated 2. Specifically, DOI >10 mm became a critical threshold, with some evidence suggesting DOI >20 mm may be an even more optimal cutoff for T4 definition 3.
Why ENE Was Added
ENE represents one of the most adverse prognostic factors in oral cavity cancer 4, 1. Patients with pathological ENE demonstrated dramatically worse outcomes:
- Regional control at 5 years: 91% (pN-) vs 80% (pN+ without ENE) vs 68% (pN+ with ENE)
- Distant control: 97% vs 87% vs 68%
- Overall survival: 75% vs 53% vs 39% 4
The incorporation of ENE resulted in 42% of node-positive patients being upstaged to N3b, creating better separation of survival curves across stage groups 4.
Clinical Impact
Stage Migration
Implementation of the 8th edition resulted in substantial upstaging 2, 3:
- 14.4% upstaged in T category (primarily due to DOI)
- 4.0-20.5% upstaged in N category (due to ENE)
- 13.2-49.1% upstaged in overall TNM stage
- 41.5% of patients overall were upstaged 2, 3
Improved Prognostic Performance
The 8th edition demonstrates superior prognostic discrimination compared to the 7th edition 2, 5, 6. The 7th edition could only significantly differentiate stage III from stage IV disease, whereas the 8th edition can distinguish between stage II and III (p=0.047) and between stage III and IV (p=0.004) 5. Concordance indices and hazard ratios improved across all stage categories 2, 6.
Critical Caveats
Measurement Challenges
DOI must be measured from the level of the adjacent normal mucosa to the deepest point of invasion, not from the surface of the tumor 1. For ulcerated tumors, reconstruction of the mucosal surface level is required. This differs from tumor thickness, which measures from the tumor surface.
Clinical vs Pathological Staging
The 8th edition parameters (DOI and ENE) are optimally assessed pathologically. Clinical DOI (cDOI) can be estimated using MRI or CT, though with less precision than pathological assessment 2. For patients receiving primary radiation without surgery, ENE prediction remains challenging and outcomes should be carefully monitored 4.
Subsite Variations
Both 7th and 8th editions perform best for tongue primaries, with some evidence suggesting that a single staging system for all oral cavity subsites may not be optimal 5. Future refinements may need to account for subsite-specific biology.